Dublin, Jan. 22, 2025 (GLOBE NEWSWIRE) — The “Cartilage Degeneration Therapy – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
The global market for Cartilage Degeneration Therapy was estimated at US$14.3 Billion in 2023 and is projected to reach US$20.9 Billion by 2030, growing at a CAGR of 5.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The demand for cartilage degeneration therapy is rising in orthopedics due to the increasing prevalence of joint disorders such as osteoarthritis, sports injuries, and age-related cartilage wear. Cartilage degeneration, which leads to pain, reduced mobility, and joint dysfunction, is a common issue that affects millions worldwide, especially among aging populations.
Therapy options, including regenerative medicine, cell-based therapies, and surgical interventions, are gaining traction as they offer solutions to restore joint function and reduce pain. As more people seek treatments to delay or avoid joint replacement surgery, cartilage regeneration and preservation therapies are becoming a crucial aspect of orthopedic care.
The Growth in the Cartilage Degeneration Therapy Market Is Driven by Several Factors
The growth in the cartilage degeneration therapy market is driven by several factors, including the rising incidence of osteoarthritis and sports-related injuries, advancements in regenerative medicine, and the growing focus on minimally invasive treatments. The aging population, combined with the increased awareness of non-surgical treatment options, is fueling demand for innovative therapies that restore joint health.
Technological advancements in cell-based therapies, tissue engineering, and biomaterials are also expanding the range of treatment options available for patients suffering from cartilage degeneration. As the need for effective joint preservation therapies increases, the cartilage degeneration therapy market is expected to experience significant growth globally.
How Are Advances in Regenerative Medicine Transforming Cartilage Degeneration Therapy?
Advances in regenerative medicine are transforming the field of cartilage degeneration therapy by providing innovative solutions such as stem cell therapy, platelet-rich plasma (PRP), and tissue engineering. Stem cell therapy, for example, involves the use of mesenchymal stem cells to regenerate damaged cartilage, offering a minimally invasive alternative to traditional surgery.
Tissue-engineered scaffolds and biomaterials are being developed to support cartilage repair and encourage the growth of new tissue. These advancements in regenerative techniques not only address the underlying degeneration but also offer the potential to enhance long-term recovery and improve patient outcomes, making them a game-changer in the treatment of cartilage-related disorders.
What Role Does the Growing Aging Population Play in the Cartilage Degeneration Therapy Market?
The growing aging population is a significant driver of the cartilage degeneration therapy market, as elderly individuals are more prone to degenerative joint conditions such as osteoarthritis. As life expectancy increases, the prevalence of joint-related disorders is expected to rise, leading to a higher demand for therapies that can preserve joint function and improve quality of life. Additionally, younger populations engaged in high-impact sports or physical activities are also contributing to the demand for treatments that address cartilage damage. As a result, therapies that provide pain relief, improve mobility, and delay the need for joint replacement are gaining prominence in the global healthcare landscape.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players in the Global Cartilage Degeneration Therapy Market such as AlloSource, Anika Therapeutics, Inc., Arthrex, Inc., B. Braun SE, Ed. Geistlich Sohne AG (Geistlich Group) and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Joint Replacements segment, which is expected to reach US$7.7 Billion by 2030 with a CAGR of a 6.2%. The Chondroplasty segment is also set to grow at 5.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $3.9 Billion in 2023, and China, forecasted to grow at an impressive 5.3% CAGR to reach $3.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 194 |
| Forecast Period | 2023 – 2030 |
| Estimated Market Value (USD) in 2023 | $14.3 Billion |
| Forecasted Market Value (USD) by 2030 | $20.9 Billion |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of COVID-19 and a Looming Global Recession
- Cartilage Degeneration Therapy – Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Increasing Prevalence of Osteoarthritis and Age-Related Joint Disorders
- Growing Adoption of Regenerative Medicine for Cartilage Degeneration Treatment
- Technological Advancements in Stem Cell and Platelet-Rich Plasma (PRP) Therapies
- Rising Demand for Minimally Invasive Cartilage Repair Solutions
- Expansion of Sports Medicine Driving Demand for Cartilage Restoration Therapies
- Technological Innovations in Tissue Engineering and Cartilage Scaffolds
- Increasing Focus on Delaying or Preventing Joint Replacement Surgeries
- Growing Awareness of Autologous Therapies for Cartilage Repair and Regeneration
- Rising Adoption of Biologics and Cell-Based Therapies in Orthopedic Care
- Expansion of Research and Clinical Trials for Advanced Cartilage Degeneration Therapies
FOCUS ON SELECT PLAYERS:Some of the 42 companies featured in this Global Cartilage Degeneration Therapy market report include
- AlloSource
- Anika Therapeutics, Inc.
- Arthrex, Inc.
- B. Braun SE
- Ed. Geistlich Sohne AG (Geistlich Group)
- Huntington Hospital
- J&J MedTech
- Smith & Nephew Plc
- Vericel Corporation
- Zimmer Biomet Holdings, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/mvd7uu
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Cartilage Degeneration Therapy Market
